LearnGlossaryMarketStocksSuperinvestorsSign in

VRBCF

Virbac S.A.

Healthcare · $3.2B market cap

Verdict

Share price

$383.25

close of Oct 1, 2026

Fair value

$300.48

Sticker Price

Payback Price

$120.19

buy price

Overpriced

VRBCF is Overpriced: at $383.25 it trades 28% above its fair value of $300.48. Its buy price (Payback Price) is $120.19, 69% below today's price. Business quality is solid: 3 of 5 key numbers clear the 10% bar.

How we valued it

Free Cash Flow. Sales grew 6% a year over the last 3 years, below the 15% we look for in a fast grower, so we value it on its free cash flow instead of an earnings forecast.

Business quality

3 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth11.5% a year✓
Equity per share growth10.3% a year✓
Sales growth6.7% a year✗
Free cash flow growth6.6% a year✗
Return on invested capital11.0%✓

Follow VRBCF

Get notified when it reaches its buy price of $120.19. Free.

Create a free account

About Virbac S.A.

Virbac S.A. is a leading global animal health company that develops, produces, and distributes a comprehensive array of products and services designed for both domestic pets and livestock. The company maintains a significant international presence, operating across numerous regions including France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. Its extensive portfolio…

Drug Manufacturers - General

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 1, 2026. How the Payback Price works